Loading page
Loading page
Loading substance route
Anecdotal reports suggest EPT has low abuse potential and does not produce dependence, similar to other unsubstituted tryptamines such as DMT, DET, and MET.
Anecdotal reports suggest EPT does not produce physical dependence.
The exact toxic dose is unknown. The toxicity and long-term health effects of recreational EPT use have not been studied in any scientific context.
EPT's original synthesis date remains unknown. The compound first appeared for sale on the online research chemical market in 2016, emerging as what appears to be an entirely novel product of clandestine drug design rather than a compound derived from academic or pharmaceutical research. Unlike…
Regulated under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act) since July 18, 2019. Production, import with intent to distribute, administration to others, and trading are criminal offenses. Personal possession is prohibited but not subject to criminal penalties.
Not listed under Buchstabe A, B, C, or D of the Swiss controlled substances regulations. Currently considered legal, though this status may change.
Not specifically scheduled under federal law. However, due to structural similarity to DMT (a Schedule I substance), it may be subject to prosecution under the Federal Analogue Act if sold for human consumption or used for illicit purposes. Legal status may vary by state.
Listed as a controlled substance under Tabella I of Italian drug legislation. Possession, production, and distribution are prohibited.
Controlled under the Misuse of Drugs Act 1971 as a result of the tryptamine catch-all clause, which encompasses tryptamine derivatives regardless of individual scheduling. Class A substances carry the most severe penalties, including up to 7 years imprisonment for possession and life imprisonment for supply.
9 sources cited